Skip to main navigation Skip to search Skip to main content

EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme

  • Bryan W. Day*
  • , Brett W. Stringer
  • , Fares Al-Ejeh
  • , Michael J. Ting
  • , John Wilson
  • , Kathleen S. Ensbey
  • , Paul R. Jamieson
  • , Zara C. Bruce
  • , Yi Chieh Lim
  • , Carolin Offenhäuser
  • , Sara Charmsaz
  • , Leanne T. Cooper
  • , Jennifer K. Ellacott
  • , Angus Harding
  • , Lucie Leveque
  • , Po Inglis
  • , Suzanne Allan
  • , David G. Walker
  • , Martin Lackmann
  • , Geoffrey Osborne
    • Kum Kum Khanna, Brent A. Reynolds, Jason D. Lickliter, Andrew W. Boyd
*Corresponding author for this work
  • Queensland Institute of Medical Research
  • University of Queensland
  • Royal Brisbane and Women's Hospital
  • BrizBrain and Spine Research Foundation
  • Monash University
  • University of Florida
  • Hudson Institute of Medical Research

Research output: Contribution to journal › Article › peer-review

192   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Neuroscience

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science